⌘K
Loading ticker…
As of 2026-08-24, Lexeo Therapeutics, Inc. Common Stock (LXEO) has a 3-month relative strength percentile of 40 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.3%, relative volume 0.56×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
LXEO is held by 13 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $2M notional. Top 3 carry $3M.
Held by 38 ETFs · $54M across latest filings · largest weight 0.43% (BBC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.03% |
| $20K |
| — |
| ITWO | 0.01% | $16K | — |
| BIB | 0.02% | $14K | — |
| URTY | 0.00% | $13K | — |
| UWM | 0.01% | $13K | — |
Showing 10 of 13 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LXEO Jan avg: -5.04% median: -17.48% win: 33% σ: 28.65% n: 3 2023-11-06 → 2026-07-31 | LXEO Feb avg: -21.71% median: -14.70% win: 0% σ: 22.93% n: 3 2023-11-06 → 2026-07-31 | LXEO Mar avg: 2.84% median: 7.25% win: 67% σ: 21.04% n: 3 2023-11-06 → 2026-07-31 | LXEO Apr avg: -2.71% median: -0.78% win: 33% σ: 17.01% n: 3 2023-11-06 → 2026-07-31 | LXEO May avg: -2.32% median: -9.74% win: 33% σ: 32.82% n: 3 2023-11-06 → 2026-07-31 | LXEO Jun avg: 11.60% median: -3.55% win: 33% σ: 31.48% n: 3 2023-11-06 → 2026-07-31 | LXEO Jul avg: -5.13% median: -11.28% win: 33% σ: 20.42% n: 3 2023-11-06 → 2026-07-31 | LXEO Aug avg: -3.51% median: -3.51% win: 50% σ: 6.76% n: 2 2023-11-06 → 2026-07-31 (current) | LXEO Sep avg: 8.58% median: 8.58% win: 50% σ: 42.48% n: 2 2023-11-06 → 2026-07-31 | LXEO Oct avg: 19.07% median: 19.07% win: 50% σ: 44.80% n: 2 2023-11-06 → 2026-07-31 | LXEO Nov avg: 9.75% median: 4.18% win: 67% σ: 14.84% n: 3 2023-11-06 → 2026-07-31 | LXEO Dec avg: -4.61% median: 0.71% win: 67% σ: 13.58% n: 3 2023-11-06 → 2026-07-31 |